Sexually Transmitted Diseases Drug Market - Global Outlook and Forecast 2021-2027

Code: RW00014556918
Market Monitor Global
Oct-2021
Life Sciences
93 Pages

This report contains market size and forecasts of Sexually Transmitted Diseases (STDs) Drug in global, including the following market information:
Global Sexually Transmitted Diseases (STDs) Drug Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Sexually Transmitted Diseases (STDs) Drug Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Sexually Transmitted Diseases (STDs) Drug companies in 2020 (%)
The global Sexually Transmitted Diseases (STDs) Drug market was valued at 21640 million in 2020 and is projected to reach US$ 30110 million by 2027, at a CAGR of 8.6% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sexually Transmitted Diseases (STDs) Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sexually Transmitted Diseases (STDs) Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Sexually Transmitted Diseases (STDs) Drug Market Segment Percentages, By Type, 2020 (%)
Chlamydia
Gonorrhea
Syphilis
Genital herpes
HPV
HIV / AIDS

Global Sexually Transmitted Diseases (STDs) Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Sexually Transmitted Diseases (STDs) Drug Market Segment Percentages, By Application, 2020 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Sexually Transmitted Diseases (STDs) Drug Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Sexually Transmitted Diseases (STDs) Drug Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sexually Transmitted Diseases (STDs) Drug revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Sexually Transmitted Diseases (STDs) Drug revenues share in global market, 2020 (%)
Key companies Sexually Transmitted Diseases (STDs) Drug sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Sexually Transmitted Diseases (STDs) Drug sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Hoffmann La Roche
Bayer Healthcare
Eli Lilly
Johnson & Johnson
Bristol-Myers Squibb
AbbVie, Inc.
Gilead Sciences
GlaxoSmithKline Plc
Merck & Co., Inc.

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Sexually Transmitted Diseases (STDs) Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sexually Transmitted Diseases (STDs) Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sexually Transmitted Diseases (STDs) Drug Overall Market Size
2.1 Global Sexually Transmitted Diseases (STDs) Drug Market Size: 2021 VS 2027
2.2 Global Sexually Transmitted Diseases (STDs) Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Sexually Transmitted Diseases (STDs) Drug Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Sexually Transmitted Diseases (STDs) Drug Players in Global Market
3.2 Top Global Sexually Transmitted Diseases (STDs) Drug Companies Ranked by Revenue
3.3 Global Sexually Transmitted Diseases (STDs) Drug Revenue by Companies
3.4 Global Sexually Transmitted Diseases (STDs) Drug Sales by Companies
3.5 Global Sexually Transmitted Diseases (STDs) Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Sexually Transmitted Diseases (STDs) Drug Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Sexually Transmitted Diseases (STDs) Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Sexually Transmitted Diseases (STDs) Drug Players in Global Market
3.8.1 List of Global Tier 1 Sexually Transmitted Diseases (STDs) Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Sexually Transmitted Diseases (STDs) Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Sexually Transmitted Diseases (STDs) Drug Market Size Markets, 2021 & 2027
4.1.2 Chlamydia
4.1.3 Gonorrhea
4.1.4 Syphilis
4.1.5 Genital herpes
4.1.6 HPV
4.1.7 HIV / AIDS
4.2 By Type - Global Sexually Transmitted Diseases (STDs) Drug Revenue & Forecasts
4.2.1 By Type - Global Sexually Transmitted Diseases (STDs) Drug Revenue, 2016-2021
4.2.2 By Type - Global Sexually Transmitted Diseases (STDs) Drug Revenue, 2022-2027
4.2.3 By Type - Global Sexually Transmitted Diseases (STDs) Drug Revenue Market Share, 2016-2027
4.3 By Type - Global Sexually Transmitted Diseases (STDs) Drug Sales & Forecasts
4.3.1 By Type - Global Sexually Transmitted Diseases (STDs) Drug Sales, 2016-2021
4.3.2 By Type - Global Sexually Transmitted Diseases (STDs) Drug Sales, 2022-2027
4.3.3 By Type - Global Sexually Transmitted Diseases (STDs) Drug Sales Market Share, 2016-2027
4.4 By Type - Global Sexually Transmitted Diseases (STDs) Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Sexually Transmitted Diseases (STDs) Drug Market Size, 2021 & 2027
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Sexually Transmitted Diseases (STDs) Drug Revenue & Forecasts
5.2.1 By Application - Global Sexually Transmitted Diseases (STDs) Drug Revenue, 2016-2021
5.2.2 By Application - Global Sexually Transmitted Diseases (STDs) Drug Revenue, 2022-2027
5.2.3 By Application - Global Sexually Transmitted Diseases (STDs) Drug Revenue Market Share, 2016-2027
5.3 By Application - Global Sexually Transmitted Diseases (STDs) Drug Sales & Forecasts
5.3.1 By Application - Global Sexually Transmitted Diseases (STDs) Drug Sales, 2016-2021
5.3.2 By Application - Global Sexually Transmitted Diseases (STDs) Drug Sales, 2022-2027
5.3.3 By Application - Global Sexually Transmitted Diseases (STDs) Drug Sales Market Share, 2016-2027
5.4 By Application - Global Sexually Transmitted Diseases (STDs) Drug Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Sexually Transmitted Diseases (STDs) Drug Market Size, 2021 & 2027
6.2 By Region - Global Sexually Transmitted Diseases (STDs) Drug Revenue & Forecasts
6.2.1 By Region - Global Sexually Transmitted Diseases (STDs) Drug Revenue, 2016-2021
6.2.2 By Region - Global Sexually Transmitted Diseases (STDs) Drug Revenue, 2022-2027
6.2.3 By Region - Global Sexually Transmitted Diseases (STDs) Drug Revenue Market Share, 2016-2027
6.3 By Region - Global Sexually Transmitted Diseases (STDs) Drug Sales & Forecasts
6.3.1 By Region - Global Sexually Transmitted Diseases (STDs) Drug Sales, 2016-2021
6.3.2 By Region - Global Sexually Transmitted Diseases (STDs) Drug Sales, 2022-2027
6.3.3 By Region - Global Sexually Transmitted Diseases (STDs) Drug Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Sexually Transmitted Diseases (STDs) Drug Revenue, 2016-2027
6.4.2 By Country - North America Sexually Transmitted Diseases (STDs) Drug Sales, 2016-2027
6.4.3 US Sexually Transmitted Diseases (STDs) Drug Market Size, 2016-2027
6.4.4 Canada Sexually Transmitted Diseases (STDs) Drug Market Size, 2016-2027
6.4.5 Mexico Sexually Transmitted Diseases (STDs) Drug Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Sexually Transmitted Diseases (STDs) Drug Revenue, 2016-2027
6.5.2 By Country - Europe Sexually Transmitted Diseases (STDs) Drug Sales, 2016-2027
6.5.3 Germany Sexually Transmitted Diseases (STDs) Drug Market Size, 2016-2027
6.5.4 France Sexually Transmitted Diseases (STDs) Drug Market Size, 2016-2027
6.5.5 U.K. Sexually Transmitted Diseases (STDs) Drug Market Size, 2016-2027
6.5.6 Italy Sexually Transmitted Diseases (STDs) Drug Market Size, 2016-2027
6.5.7 Russia Sexually Transmitted Diseases (STDs) Drug Market Size, 2016-2027
6.5.8 Nordic Countries Sexually Transmitted Diseases (STDs) Drug Market Size, 2016-2027
6.5.9 Benelux Sexually Transmitted Diseases (STDs) Drug Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Sexually Transmitted Diseases (STDs) Drug Revenue, 2016-2027
6.6.2 By Region - Asia Sexually Transmitted Diseases (STDs) Drug Sales, 2016-2027
6.6.3 China Sexually Transmitted Diseases (STDs) Drug Market Size, 2016-2027
6.6.4 Japan Sexually Transmitted Diseases (STDs) Drug Market Size, 2016-2027
6.6.5 South Korea Sexually Transmitted Diseases (STDs) Drug Market Size, 2016-2027
6.6.6 Southeast Asia Sexually Transmitted Diseases (STDs) Drug Market Size, 2016-2027
6.6.7 India Sexually Transmitted Diseases (STDs) Drug Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Sexually Transmitted Diseases (STDs) Drug Revenue, 2016-2027
6.7.2 By Country - South America Sexually Transmitted Diseases (STDs) Drug Sales, 2016-2027
6.7.3 Brazil Sexually Transmitted Diseases (STDs) Drug Market Size, 2016-2027
6.7.4 Argentina Sexually Transmitted Diseases (STDs) Drug Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Sexually Transmitted Diseases (STDs) Drug Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Sexually Transmitted Diseases (STDs) Drug Sales, 2016-2027
6.8.3 Turkey Sexually Transmitted Diseases (STDs) Drug Market Size, 2016-2027
6.8.4 Israel Sexually Transmitted Diseases (STDs) Drug Market Size, 2016-2027
6.8.5 Saudi Arabia Sexually Transmitted Diseases (STDs) Drug Market Size, 2016-2027
6.8.6 UAE Sexually Transmitted Diseases (STDs) Drug Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Sexually Transmitted Diseases (STDs) Drug Major Product Offerings
7.1.4 Pfizer Sexually Transmitted Diseases (STDs) Drug Sales and Revenue in Global (2016-2021)
7.1.5 Pfizer Key News
7.2 Hoffmann La Roche
7.2.1 Hoffmann La Roche Corporate Summary
7.2.2 Hoffmann La Roche Business Overview
7.2.3 Hoffmann La Roche Sexually Transmitted Diseases (STDs) Drug Major Product Offerings
7.2.4 Hoffmann La Roche Sexually Transmitted Diseases (STDs) Drug Sales and Revenue in Global (2016-2021)
7.2.5 Hoffmann La Roche Key News
7.3 Bayer Healthcare
7.3.1 Bayer Healthcare Corporate Summary
7.3.2 Bayer Healthcare Business Overview
7.3.3 Bayer Healthcare Sexually Transmitted Diseases (STDs) Drug Major Product Offerings
7.3.4 Bayer Healthcare Sexually Transmitted Diseases (STDs) Drug Sales and Revenue in Global (2016-2021)
7.3.5 Bayer Healthcare Key News
7.4 Eli Lilly
7.4.1 Eli Lilly Corporate Summary
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Sexually Transmitted Diseases (STDs) Drug Major Product Offerings
7.4.4 Eli Lilly Sexually Transmitted Diseases (STDs) Drug Sales and Revenue in Global (2016-2021)
7.4.5 Eli Lilly Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Sexually Transmitted Diseases (STDs) Drug Major Product Offerings
7.5.4 Johnson & Johnson Sexually Transmitted Diseases (STDs) Drug Sales and Revenue in Global (2016-2021)
7.5.5 Johnson & Johnson Key News
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Corporate Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Sexually Transmitted Diseases (STDs) Drug Major Product Offerings
7.6.4 Bristol-Myers Squibb Sexually Transmitted Diseases (STDs) Drug Sales and Revenue in Global (2016-2021)
7.6.5 Bristol-Myers Squibb Key News
7.7 AbbVie, Inc.
7.7.1 AbbVie, Inc. Corporate Summary
7.7.2 AbbVie, Inc. Business Overview
7.7.3 AbbVie, Inc. Sexually Transmitted Diseases (STDs) Drug Major Product Offerings
7.4.4 AbbVie, Inc. Sexually Transmitted Diseases (STDs) Drug Sales and Revenue in Global (2016-2021)
7.7.5 AbbVie, Inc. Key News
7.8 Gilead Sciences
7.8.1 Gilead Sciences Corporate Summary
7.8.2 Gilead Sciences Business Overview
7.8.3 Gilead Sciences Sexually Transmitted Diseases (STDs) Drug Major Product Offerings
7.8.4 Gilead Sciences Sexually Transmitted Diseases (STDs) Drug Sales and Revenue in Global (2016-2021)
7.8.5 Gilead Sciences Key News
7.9 GlaxoSmithKline Plc
7.9.1 GlaxoSmithKline Plc Corporate Summary
7.9.2 GlaxoSmithKline Plc Business Overview
7.9.3 GlaxoSmithKline Plc Sexually Transmitted Diseases (STDs) Drug Major Product Offerings
7.9.4 GlaxoSmithKline Plc Sexually Transmitted Diseases (STDs) Drug Sales and Revenue in Global (2016-2021)
7.9.5 GlaxoSmithKline Plc Key News
7.10 Merck & Co., Inc.
7.10.1 Merck & Co., Inc. Corporate Summary
7.10.2 Merck & Co., Inc. Business Overview
7.10.3 Merck & Co., Inc. Sexually Transmitted Diseases (STDs) Drug Major Product Offerings
7.10.4 Merck & Co., Inc. Sexually Transmitted Diseases (STDs) Drug Sales and Revenue in Global (2016-2021)
7.10.5 Merck & Co., Inc. Key News
8 Global Sexually Transmitted Diseases (STDs) Drug Production Capacity, Analysis
8.1 Global Sexually Transmitted Diseases (STDs) Drug Production Capacity, 2016-2027
8.2 Sexually Transmitted Diseases (STDs) Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Sexually Transmitted Diseases (STDs) Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Sexually Transmitted Diseases (STDs) Drug Supply Chain Analysis
10.1 Sexually Transmitted Diseases (STDs) Drug Industry Value Chain
10.2 Sexually Transmitted Diseases (STDs) Drug Upstream Market
10.3 Sexually Transmitted Diseases (STDs) Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Sexually Transmitted Diseases (STDs) Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Sexually Transmitted Diseases (STDs) Drug in Global Market
Table 2. Top Sexually Transmitted Diseases (STDs) Drug Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Sexually Transmitted Diseases (STDs) Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Sexually Transmitted Diseases (STDs) Drug Revenue Share by Companies, 2016-2021
Table 5. Global Sexually Transmitted Diseases (STDs) Drug Sales by Companies, (K Units), 2016-2021
Table 6. Global Sexually Transmitted Diseases (STDs) Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Sexually Transmitted Diseases (STDs) Drug Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Sexually Transmitted Diseases (STDs) Drug Product Type
Table 9. List of Global Tier 1 Sexually Transmitted Diseases (STDs) Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sexually Transmitted Diseases (STDs) Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE